Molecular Partners - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeMolecular Partners
Molecular Partners logo

Molecular Partners

0 followers

MOLN

Performance

About Molecular Partners

Molecular Partners is a Swiss biotechnology company focused on developing DARPin-based therapeutics for cancer and other serious diseases. The company specializes in radiopharmaceuticals, immune cell engagers, and multi-specific DARPins, including Radio-DARPins and Switch-DARPins, to go beyond today’s cancer treatments. Its pipeline highlights multispecific and targeted approaches for solid tumors and hematologic cancers, with programs such as DLL3 and other cancer targets. Headquartered in Switzerland, Molecular Partners collaborates with partners and maintains an international presence in oncology research.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

Jason McCune

COO

Key Facts

HQ Location

Switzerland

Founded

2004

Employees

51 - 200

Status

Investor

Investor Type

Venture Investor

Website

https://molecularpartners.com